Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

5 articles from the last 90 days matching "rare disease diagnosis"

ResearchPUBMEDApr 16

Targeted long-read RNA sequencing for rare disease diagnosis and variant interpretation.

Scientists created a new tool called STRIPE that uses advanced genetic testing to read long strands of RNA (the instructions cells use to make proteins). This tool can detect genetic mistakes that cause rare diseases by looking at how genes are actually working in cells, not just finding the mutations themselves. It's designed to be faster, cheaper, and more practical than older methods, which could help doctors diagnose rare genetic diseases that are hard to identify.

WHY IT MATTERSPatients with undiagnosed rare genetic diseases could finally get answers through more accurate genetic testing, since STRIPE can detect disease-causing variants that standard DNA tests might miss.
Good to knowRead →
ResearchBIORXIVApr 14

Preprint: CoNVict: An Agentic AI System for Copy Number Variation Prioritization in Rare Disease Diagnosis

Scientists created a new AI system called CoNVict that helps doctors figure out which genetic changes are actually causing rare diseases. Copy number variants (CNVs) are sections of DNA that are duplicated or missing, and they can cause genetic disorders, but it's hard to know which ones matter. This new tool uses artificial intelligence to automatically score and rank these genetic changes so doctors can focus on the ones most likely to be causing a patient's symptoms.

WHY IT MATTERSIf your child has unexplained developmental delays or birth defects and genetic testing found copy number variants, this AI tool could help doctors identify which variant is actually responsible for your child's condition, potentially speeding up diagnosis.
👁 Watch this spaceRead →
ResearchPUBMEDApr 1

Advancing Neuropediatric Rare Disease Diagnosis Through Clinical Genome Sequencing.

Researchers in Italy tested a new way to diagnose rare genetic diseases in children using whole genome sequencing—a test that reads all of a person's genetic code. Between 2018 and 2022, they studied 64 children with complex neurological problems that doctors couldn't figure out. This study shows whether this genetic test could help find answers faster for kids with mysterious rare diseases.

WHY IT MATTERSIf your child has unexplained neurological symptoms and multiple doctors haven't found a diagnosis, this research demonstrates that whole genome sequencing through healthcare systems may finally provide answers—potentially ending years of diagnostic uncertainty.
💬 Ask your doctorrare genetic neuropediatric diseasesundiagnosed genetic disorders in childrenmonogenic neurological diseasesRead →
ResearchPUBMEDMar 26

Long-term survival outcomes of female genital tract rhabdomyosarcoma in children, adolescents and young adults at a national rare disease diagnosis and treatment center in China.

Researchers in China studied 26 children and young adults (average age 8 years old) who had a rare cancer called rhabdomyosarcoma that started in the female reproductive organs. They tracked these patients for an average of nearly 5 years to see how well different treatments worked. This study helps doctors understand the best ways to treat this uncommon type of cancer in girls and young women.

WHY IT MATTERSThis is the first large study from China showing long-term survival rates for girls with genital rhabdomyosarcoma, which can help doctors worldwide improve treatment plans and give families more accurate information about what to expect.
💬 Ask your doctorRhabdomyosarcomaFemale genital tract rhabdomyosarcomaGenitourinary rhabdomyosarcomaRead →
ResearchPUBMEDMar 26

An agentic system for rare disease diagnosis with traceable reasoning.

Researchers created DeepRare, a computer system that helps doctors diagnose rare diseases faster and more accurately. The system uses artificial intelligence to analyze patient information like symptoms, genetic test results, and medical history to suggest possible diagnoses. This could help patients avoid the long 'diagnostic odyssey' where they see many doctors over years before getting a correct diagnosis.

WHY IT MATTERSPatients with rare diseases spend an average of 5+ years seeking diagnosis with repeated misdiagnoses; DeepRare could dramatically shorten this timeline by providing doctors with AI-powered diagnostic support that integrates genetic and phenotype data.
Good to knowrare diseases (general)Read →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases